Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis

Journal of Periodontology

Volumn 80, Issue 9, 2009, Pages 1414-1420

  Mayer, Yaniv ^a   Balbir Gurman, Alexandra ^b,c   MacHtei, Eli E ^a,b  

^a Endodontics and Dental Trauma Unit   (Israel)

^b B Shine Department of Rheumatology   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Anti inflammatory agents; Cytokines; Immunology; Periodontium; Pharmacology

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM; RHEUMATOID ARTHRITIS; TOOTH PLAQUE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 69949189640     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090015     Document Type: Article

References (39)

1. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14:33-53.
2. Williams RC. Periodontal disease. N Engl J Med 1990; 322:373-382.
3. Weyand CM. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology 2000;39(Suppl. 1): 3-8.
4. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001;72:779-787.
5. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol 2003;30:761-772.
6. Lagervall M, Jansson L. Bergstrom J. Systemic disorders in patients with periodontal disease. J Clin Peri-odontol 2003;30:293-299.
7. Havemose-Poulsen A, Westergaard J, Stoltze K, et al. Periodontal and hematological characteristics associated with aggressive periodontitis, uvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2006; 77:280-288.
8. Nanes MS. Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1-15.
9. Bascones A, Gamonal J, Gomez M, Silva A, Gonzalez MA. New knowledge of the pathogenesis of periodon- tal disease. Quintessence Int 2004;35:706-716.
10. Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008;214:149-160.
11. Pfizenmaier K, Wajant H, Grell M. Tumor necrosis factors in 1996. Cytokine Growth Factor Rev 1996; 7:271-277.
12. Rai B, Kharb S, Jain R, Anand SC. Biomarkers of periodontitis in oral fluids. J Oral Sci 2008;50:53-56.
13. Williams RO. Cartilage destruction and bone erosion in arthritis: The role of tumour necrosis factor alpha. Ann Rheum Dis 2000;59:75-80.
14. Delima AJ, Oates T, Assuma R, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001;28: 233-240.
15. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998;160:403-409.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
17. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-48.
18. Westergren A. The technique of the red cell sedimentation reaction. Am Rev Tuberc 1926;14:94-101.
19. Silness J, Loë H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
20. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
21. Machtei EE, Younis MN. The use of two antibiotics regimens in aggressive periodontitis: Comparison of changes in clinical parameters and GCF biomarkers. Quintessence Int 2008;39:811-820.
22. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Peri-odontol 1999;4:1-6.
23. Ebersole JL, Singer RE, Steffensen R, Filloon T, Kornman KS. Inflammatory mediators and immuno- globulins in GCF from healthy, gingivitis and peri-odontitis sites. J Periodontal Res 1993;28:543-546.
24. Lamster IB. Application of new methodology to the study of gingival crevicular fluid. In: Myers HM, ed. New Biotechnology in Oral Research. Basel, Switzerland: S. Karger; 1989:90-117.
25. Bang JS, Cimasoni G. Total protein in human crevicular fluid. J Dent Res 1971;50:1683.
26. Curtis MA, Griffiths GS, Price SJ, Coulthurst SK, Johnson MW. The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation. J Clin Periodontol 1988;15: 628-632.
27. Tollefsen T, Saltvedt E. Comparative analysis of gingival fluid and plasma by crossed immunoelectrophoresis. J Periodontal Res 1980;15:96-106.
28. Lamster IB, Oshrain RL, Gordon JM. Enzyme activity in human gingival crevicular fluid: Considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 1986;13:799-804.
29. Tsai CC, Ho YP, Chen CC. Levels of interleukin-1 β and interleukin-8 in gingival crevicular fluids in adult peri-odontitis. J Periodontol 1995;66:852-859.
30. Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol 2007;34:18-24.
31. Kurtiş B, Tüter G, Serdar M, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein- 1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005;76:1849-1855.
32. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-1563.
33. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor:Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340: 253-259.
34. Elliott MJ, Maini RN, Feldmann M, Jr., et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-1110.
35. Moreland LW, Margolies G, Heck LW Jr., et al. Re-combinant soluble tumor necrosis factor receptor (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis. J Rheumatol 1996;23:1849-1855.
36. Pers JO, Saraux A, Pierre R, Youinou P. Anti TNF-α immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol 2008; 79:1645-1651.
37. Nilsson M, Kopp S. Gingivitis and periodontitis are related to repeated high levels of circulating tumor necrosis factor-alpha in patients with rheumatoid arthritis. J Periodontol 2008;79:1689-1696.
38. Sjostrom L, Laurell L, Hugoson A, Hakansson JP. Periodontal conditions in adults with rheumatoid arthritis. Community Dent Oral Epidemiol 1989;17:234-236.
39. Kässer UR, Gleissner C, Dehne F, Michel A, Willershausen-Zonnchen B, Bolten WW. Risk for peri- odontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997;40:2248-2251.